MY

Mohd Yaqub Mir

Active Director Director DIN 07149881
DIN 07149881 First appointment Apr 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Mohd Yaqub Mir

Data last updated:

Mohd Yaqub Mir is a Director at Neomac Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Neomac Pharmaceuticals Private Limited reported revenue of ₹8.43 Cr (FY 2024).

DIN 07149881
Primary Designation Director
Industry Pharma
First Appointment 10 Apr 2015
Oldest Company Age 11 yrs
Largest company Neomac Pharmaceuticals Private Limited · ₹8.43 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20152015₹8.43 Cr (FY 2024)Active

Board colleagues of Mohd Yaqub Mir

Directorship timeline

Open interactive timeline →
Neomac Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohd Yaqub Mir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Yaqub Mir

Mohd Yaqub Mir currently holds 1 directorship: Neomac Pharmaceuticals Private Limited (Director, since 10 Apr 2015, revenue ₹8.43 Cr (FY 2024)).

Mohd Yaqub Mir was first appointed on 10 Apr 2015 as Director at Neomac Pharmaceuticals Private Limited.

The current boards of Mohd Yaqub Mir's companies include Naresh Mahajan (Neomac Pharmaceuticals Private Limited), Sahil Mahajan (Neomac Pharmaceuticals Private Limited), Shabir Ahmad Bhat (Neomac Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available